BMJ 2007;334:249-253 (3 February), doi:10.1136/bmj.39073.736829.BE
Clinical Review
Endometriosis
Cynthia Farquhar, postgraduate professor in obstetrics and gynaecology
1 Department of Obstetrics and Gynaecology, National Women's Hospital, University of Auckland, Auckland, New Zealand
c.farquhar@auckland.ac.nz
| The first 150 words of the full text of this article appear below. |
Endometriosis is a chronic condition characterised by growth of endometrial tissue in sites other than the uterine cavity, most commonly in the pelvic cavity, including the ovaries, the uterosacral ligaments, and pouch of Douglas (fig 1).
Common symptoms include dysmenorrhoea, dyspareunia, non-cyclic pelvic pain, and subfertility (table 1).
The clinical presentation is variable, with some women experiencing several severe symptoms and others having no symptoms at all. The prevalence in women without symptoms is 2-50%, depending on the diagnostic criteria used and the populations studied.1 The incidence is 40-60% in women with dysmenorrhoea and 20-30% in women with subfertility.w1-w3 The severity of symptoms and the probability of diagnosis increase with age.w4 The most common age of diagnosis is reported as around 40, although this figure came from a study in a cohort of women attending a family planning clinic.w5 Symptoms and laparoscopic appearance do not always correlate.2 The American Society . . . [Full text of this article]

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Relevant Article
-
Infertility set in context
- Alejandro Chavez-Badiola and Andrew J Drakeley
BMJ 2007 334: 328.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:
-
Stephansson, O., Kieler, H., Granath, F., Falconer, H.
(2009). Endometriosis, assisted reproduction technology, and risk of adverse pregnancy outcome. Hum Reprod
0: dep186v4-dep186
[Abstract]
[Full text]
-
Kvaskoff, M., Mesrine, S., Clavel-Chapelon, F., Boutron-Ruault, M.-C.
(2009). Endometriosis risk in relation to naevi, freckles and skin sensitivity to sun exposure: the French E3N cohort. Int J Epidemiol
0: dyp175v1-dyp175
[Abstract]
[Full text]
-
Day, J. M, Tutill, H. J, Purohit, A., Reed, M. J
(2008). Design and validation of specific inhibitors of 17{beta}-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis. Endocr Relat Cancer
15: 665-692
[Abstract]
[Full text]
-
Zhang, X., Yuan, H., Deng, L., Hu, F., Ma, J., Lin, J.
(2008). Evaluation of the efficacy of a danazol-loaded intrauterine contraceptive device on adenomyosis in an ICR mouse model. Hum Reprod
23: 2024-2030
[Abstract]
[Full text]
-
Manderson, L., Warren, N., Markovic, M.
(2008). Circuit Breaking: Pathways of Treatment Seeking for Women With Endometriosis in Australia. Qual Health Res
18: 522-534
[Abstract]
-
Banu, S. K., Lee, J., Speights, V. O. Jr., Starzinski-Powitz, A., Arosh, J. A.
(2008). Cyclooxygenase-2 Regulates Survival, Migration, and Invasion of Human Endometriotic Cells through Multiple Mechanisms. Endocrinology
149: 1180-1189
[Abstract]
[Full text]
-
Styer, A. K., Sullivan, B. T., Puder, M., Arsenault, D., Petrozza, J. C., Serikawa, T., Chang, S., Hasan, T., Gonzalez, R. R., Rueda, B. R.
(2008). Ablation of Leptin Signaling Disrupts the Establishment, Development, and Maintenance of Endometriosis-Like Lesions in a Murine Model. Endocrinology
149: 506-514
[Abstract]
[Full text]
-
Chavez-Badiola, A., Drakeley, A. J
(2007). Infertility set in context. BMJ
334: 328-328
[Full text]
Rapid Responses:
Read all Rapid Responses
- Infertility in the context of endometriosis
- Alejandro Chavez-Badiola, et al.
bmj.com, 7 Feb 2007
[Full text]
- P.E./Sport and the Aetiology of Endometriosis
- Marie B McDevitt
bmj.com, 18 Feb 2007
[Full text]
- Endometriosis in an evolutionary perspective
- Vercellini Paolo, et al.
bmj.com, 23 Feb 2007
[Full text]
- Exercise and Endometriosis
- Carl De Crée
bmj.com, 4 Mar 2007
[Full text]